Latest news
Loading news…
Alpine Immune Sciences
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Seattle, Washington, United States Founded 2015 51-100 employees For Profit
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Alpine Immune Sciences on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Alpine Immune Sciences was acquired by Vertex Pharmaceuticals in 2024 for $4.9B.
Total Funding
$325.3M
Funding Rounds
6
Last Funding
Acquisitions
1
Monthly Visits
Contacts
97
Patents
52
1 trademarks
About Alpine Immune Sciences
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- ALPN
- Exchange
- NASDAQ
- IPO date
- Jul 25, 2017
- Delisted
- May 19, 2024
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 9
- Active products
- 18
- Patents granted
- 52
- Trademarks
- 1
- Top patent class
- Organic Chemistry
- IT spend
- $8.82M
Company Info
- Founded
- 2015
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 129
- HQ
- Seattle, Washington, United States
- Region
- Greater Seattle Area, West Coast, Western US
- Exit date
- Jul 25, 2017
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 2.7
- Trend (30d)
- 1.1
- Trend (90d)
- -0.7
- Last leadership hire
- Oct 4, 2023
Alpine Immune Sciences Funding Rounds
6 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 6Show
Page 1 / 2
Alpine Immune Sciences Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Nivalis Therapeutics | — | 2017-07-20 | Alpine Immune Sciences | BiotechnologyHealth CareTherapeutics | United States |
1–1 of 1Show
Page 1 / 1
Alpine Immune Sciences Key People
Co-founder Executive Chairman & CEO
Co-founder and Executive Chairman
Vice President, Clinical Affairs
Chief Business Officer
Scientific Advisor
Senior Director Clinical Biomarkers (Translational Medicine)
97
professional contacts at Alpine Immune Sciences
Contact execs at Alpine Immune Sciences →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Alpine Immune Sciences
Loading news…
FAQs about Alpine Immune Sciences
People who checked this page also checked these
Sectors Alpine Immune Sciences invests & acquires in
Browse the full Acquirezy directory.